Induction of tyrosine aminotransferase (EC 2.6.1.5) with cortisol is followed by a rapid phase of inactivation of the enzyme, during which administration of puromycin causes a sharp increase in enzyme activity. The increase is not due to puromycin-resistant synthesis of protein, since precipitation of the enzyme with antibodies to tyrosine amirnotransferase after pulse labeling inhibited incorporation of radioactive amino acids. Reactivation of the enzyme was specific, since the structurally similar dimethylaminopurine and purine aminonucleoside were ineffective. An action of puromycin other than its capacity to inhibit protein synthesis was required for reactivation, since cycloheximide did not demonstrate such an effect. In vitro studies with free and bound polysomes, isolated during the phase of inactivation, indicated that reactivation by puromycin was not due to release of nascent tyrosine aminotransferase peptides. We conclude that the enzyme is initially reversibly inactivated; therefore, the overall degradation of this intracellular protein is a multistep phenomenon.
Cells from higher organisms contain a characteristic quantity of protein, most of which is in a continual state of turnover (1) (2) (3) at rates varying with individual proteins (4) . For example, one-half the ornithine decarboxylase in rat liver is replenished about every 11 min (5), while about 4-5 days are required for one-half the arginase to be degraded and resynthesized (6) . The mean turnover, or half-time (t 1/2), of soluble liver protein is about 3 days (7, 8) . Since liver cells divide infrequently, as evidenced by only one mitosis per 10,000-20,000 cells observed (9) , the average generation time of the rat liver hepatocyte has been estimated to be several months to 1 year. Therefore, soluble liver protein is degraded and synthesized many times over the lifetime of a given cell.
For prevention of unusual deviations in concentration of these proteins there must be integrated control of both the synthesizing and degrading mechanisms; that is, the net change in enzyme concentration over a given period should approach zero. One method for such coordination is by a constant input of enzyme (zero order synthesis) and an output proportional to the concentration of the protein being synthesized (first order degradation). In this type of control the concentration of enzyme can be regulated, without the mediation of complicated feedback mechanisms, by some device sensitive only to concentration of enzyme. A consequence of such a mechanism is that induction or suppression of enzyme activity may occur not only as a result of alteration of the rate of enzymatic synthesis, but also by adjustment of (Table 2 ). Moreover, in agreement with previous findings (18) , synthesis of TA returns to control levels (261 cpm/100 mg protein) during the latter phase of the induction cycle ( Table 2 ).
The capacity of puromycin to reactivate TA is limited to a finite period of the induction cycle. There was no reactivation Frozen livers from the experiments of Fig. 1 were thawed. About 3 g were homogenized in 6 ml 0.1 M sodium phosphate (pH 7.5) containing 2-oxoglutarate, 1 mM; pyridoxal phosphate, 0.1 mM; and ethylenediamine tetraacetic acid (EDTA), 0.1 mM; centrifuged at 15,000 X g for 30 min and again at 100,000 X g for 1 hr. 3-ml Aliquots were heated at 570 for 3 min, immersed in a salt water bath at about -10°for 30 min, and centrifuged. TA activity was intact in the supernatant. To 1.0-ml aliquots of the supernatant fractions, sufficient purified nonradioactive TA was added to bring the level of enzyme activity up to that contained in the most active fraction. Volume was adjusted to 1.5 ml with the above buffer and each fraction was precipitated with 20% excess antibody to TA. After 1 hr at 370 and then overnight at 40, there was no detectable enzyme activity. Precipitated enzyme was recovered by centrifugation, washed 3 times with 1 ml of 0.1 M sodium phosphate in saline (pH 7.2), dissolved in 0.2 ml of 0.1 N KOH, and quantitatively transferred to counting vials [1st precipitate (ppt)]. Purified nonradioactive enzyme was again added to the supernatants of the first precipitation and the above procedure was performed again to obtain a second antibody precipitate. Radioactivity in the 1st ppt minus that in the 2nd ppt represents radioactivity in TA.
of enzyme activity 16 hr after administration of cortisol (Fig.  1B) . The earlier reactivation of TA appears to be dependent on the entire structure of the molecule, since neither dimethylaminopurine nor puromycin aminonucleoside reactivated the enzyme in doses that have no effect on synthesis of mouse liver proteins (19) . Also, inhibition of protein synthesis by cycloheximide was not accompanied by reactivation of the enzyme, although it prevented further inactivation (Fig. 2) .
Puromycin acts as a peptide-tRNA acceptor, causing formation and release of puromycyl-peptides (21) (22) (23) , while cycloheximide appears to inhibit initiation and elongation of polypeptide chains (24, 25) . It seemed possible that the apparent reactivation of TA by puromycin might be merely release of nascent enzyme chains present on polysomes. Free and bound polysomes, shown in a control experiment to be functional, were accordingly isolated from rat livers during the rapid phase of enzyme synthesis (3 hr after administration of cortisol) and during the inactivation phase of the induction cycle (9 hr after administration of cortisol). The data in Table  3 indicate that methoxy-[3Hjpuromycin was incorporated into CleCCOOH-precipitable material during incubation with free polysomes at 37°. Little incorporation was noted with bound polysomes. No difference in methoxy-[3Hjpuromycin uptake or increment in TA was observed between free poly- Changes in TA activity after administration of cortisol, dimethylaminopurine, puromycin aminonucleoside, and cycloheximide. (A) Six rats were anesthetized with pentobarbital (30 mg/kg of body weight) and liver biopsy samples were taken. Cortisol (10 mg) was administered (zero time) and additional biopsies were taken 6 and 8 hr later. At the times indicated by arrows, half the animals were injected with 3 mg of puromycin aminonucleoside (formula shown *-), and the other half with 2 mg of dimethylaminopurine (upper half of formula shown 0-O). Doses were adjusted so that the molar concentration was about the same as for puromycin (Fig. 1) . Points represent average TA activities expressed as ,umol of p-hydroxyphenylpyruvate formed/hr per 100 mg of liver. All injections were intraperitoneal. (B) Rats were anesthetized and their liver biopsies were removed as indicated above. Cortisol was administered to 5 rats and saline was administered to 2 rats. Biopsy samples were taken 6 hr later. 7.5 hr After administration of cortisol, cycloheximide (100 ,ug/100 g of body weight) was injected into 3 rats that were treated with cortisol (A A) and into two rats that were treated with saline (0 0), as indicated by the arrows. The two other rats that were treated with cortisol were injected with saline (O-O). Additional liver biopsies were taken as indicated. Each point represents the average TA activity for each group of animals. Free and bound polysomes were isolated from the livers as in (14) . Polysome pellets were suspended in 6.0 ml of ice-cold Tris buffer (pH 7.5 50 mM; MgC12, 5 mM; KC1, 25 mM; and sucrose, 250 mM). To 0.9 ml of suspension was added 0.1 ml methoxy-
[3H]puromycin (10 MICi/ml, 1 Ci/mol). After 10 min at 0°or 370, 0.2 ml was taken for TA assay and to the remainder, 0.8 ml of 10% C13CCOOH was added. The precipitate was centrifuged, washed 3 times with 5 ml of 5% C13CCOOH, dissolved in 0.2 ml of 0.1 N KOH, and counted. TA activity was not changed. (10) . Complete conversion of (E,) to an irreversibly inactivated (ed) form occurs, however, by the time enzyme activity returns to near basal levels (Fig. 1B) , since puromycin does not then reactivate the enzyme. Therefore, the major conclusion we infer is that the intracellular degradation process of TA is complex and involves more than a single-step 
